Select Page

Company for sale

  • Size: Small
  • Revenue: < 20 million CAD
  • Location: Southern Europe
  • CFIE PHS180

 

Overview of EU GMP pharmaceutical factory in Southern Europe for sale

A pharmaceutical EU-GMP factory in Southern Europe is now available for acquisition. First, this turn-key facility spans approximately 128,000 square feet (around 11,870 square meters). Second, it is a state-of-the-art pharmaceutical EU GMP designed extraction facility.

Profile of EU-GMP pharmaceutical factory in Southern Europe for sale

Overall, the company’s profile reflects a comprehensive manufacturing infrastructure tailored for pharmaceutical production. Altogether, this includes two industrial buildings, an office area, a reception, external deposits, an internal parking area, and green spaces. In total, the office area spans 6,460 square feet and is equipped with meeting rooms, break/coffee areas, open spaces, private offices, and directive offices.

Activities and products of the EU-GMP pharmaceutical factory in Southern Europe for sale

One of the industrial buildings covers 7,750 square feet and houses an automated warehouse and a transformation area for starting materials. In addition, it is adjoined by an 11,620-square-foot greenhouse powered by a 100kWh photovoltaic solar system. Next, the second industrial building, which spans 16,140 square feet, features a dedicated ATEX rated extraction area of 2,150 square feet. More specifically, it is equipped with an industrial cryogenic-ethanol extraction unit capable of processing up to 1,500 kilos of biomass per day. Further, it is also connected to an external stainless steel silo storage system with a total capacity of 200 tons.

Additionally, the facility includes a fully equipped internal laboratory with microbiological, analytical, and preparative labs. Moreover, there is a pilot ATEX extraction area for research and technological transfer. Notably, the production area is rated ISO-8 and ATEX compliant. In particular, it features a dedicated HVAC system eligible for EU-GMP authorization. In this case, to produce active pharmaceutical ingredients, formulate products, and handle packaging and distribution operations.

Highlights of the  EU-GMP pharmaceutical factory in Southern Europe for sale

  • Fully automated operations with remote-controlled badge access, TVCC, and thermal camera systems
  • Strategic advantage in obtaining authorizations for cosmetic, food supplement, and pharmaceutical sectors
  • Significant investment of approximately 30 million CAD in the facility
  • Mortgage-free and free of debts/lender obligations, making it an attractive investment opportunity

More information on this eU GMP pharmaceutical factory in Southern Europe for sale

Please get in touch if you are interested in learning more about this eU GMP pharmaceutical factory in Southern Europe for sale. For more pharma companies for sale please visit the section pharma companies for sale. For other pharma buyers, please visit the section pharma companies wanted. If you are instead interested in pharma companies for sale, please visit the pharma companies for sale section. For pharma buyers, please visit the section pharma companies wanted.

Subscribe as an interested buyer for this Pharma company for sale

en_GBEnglish (UK)